Cryptococcosis in the immunocompromised host with special reference to AIDS.
Cryptococcosis is increasing because of an ever rising population of immunocompromised individuals especially those with acquired immune deficiency syndrome (AIDS). Cryptococcal infection of the central nervous system (CNS) were diagnosed in 149 cases over a period of 19.5 years (January 1978-June 1998). Culture was positive in all cases except three who were already on antifungal therapy. India ink mounts of cerebrospinal fluid (CSF) revealed encapsulated cryptococci in 134, and cryptococcal antigen was detected in 111 of 114 patients tested. A comparison of laboratory and certain clinical parameters in patients with and without associated HIV infection showed that a poor CSF cell response and culture of cryptococci from extra-neural sites was more often associated with HIV infection and was statistically significant. Further, presence of concomitant infection especially tuberculosis, and mortality were higher in the HIV positive group.
Khanna
N
N
Department of Neuromicrobiology, National Institute of Mental Health and Neurosciences, Bangalore. nkhanna@nimhans.kar.nic.in
Chandramuki
A
A
Desai
A
A
Ravi
V
V
Santosh
V
V
Shankar
S K
SK
Satishchandra
P
P
D017088:AIDS-Related Opportunistic Infections / Q000209:etiology* / Q000473:pathology*; D000935:Antifungal Agents / Q000627:therapeutic use; D002555:Cerebrospinal Fluid / Q000382:microbiology; D003453:Cryptococcosis / Q000209:etiology* / Q000276:immunology / Q000473:pathology*; D003455:Cryptococcus neoformans / Q000302:isolation & purification / Q000472:pathogenicity; D006801:Humans; D016867:Immunocompromised Host; D016919:Meningitis, Cryptococcal / Q000209:etiology* / Q000276:immunology / Q000473:pathology*; D012189:Retrospective Studies
D000935:Antifungal Agents